Doi
https://doi.org/10.23822/EurAnnACI.1764-1489.37
Summary
Anticonvulsants are among the drugs most commonly involved in cutaneous adverse drug reactions (CADRs). Eslicarbazepine is a new anti-epileptic drug, chemically related to carbamazepine but with a more favorable safety profile. We report the clinical case of a woman who developed a skin rash on day 10 of eslicarbazepine with further exacerbation with eosinophilia on day 2 of carbamazepine. Epicutaneous tests were positive with eslicarbazepine.
Key words
eslicarbazepine; anticonvulsant drugs; skin rash; drug allergy; epicutaneous tests
Cite this article as:
Finelli E, Custódio P, Porovska O, Prates S, Leiria-Pinto P. Patch testing in a case of eslicarbazepine and carbamazepine induced cutaneous reaction . Eur Ann Allergy Clin Immunol. 2018;50(5):229-231. doi:10.23822/EurAnnACI.1764-1489.37